Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031105

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Countouriotis Athena Director 2024-03-01 Grant or award · Deferred Restricted Stock Unit +50,000 50,000 D: show line 1 in the form
Loading xslF345X05/tm248017d1_4seq1.xml…